Combined Predictors for the Diagnostic Transition from Acute and Transient Psychotic Disorder to Schizophrenia: A Retrospective Study
Yanyan Lu,Qiang Wang,Xuzhen Liu,Shuzhan Gao,Sulin Ni,Jing Sun,Xijia Xu
DOI: https://doi.org/10.2147/ndt.s470127
IF: 2.989
2024-10-27
Neuropsychiatric Disease and Treatment
Abstract:Yanyan Lu, 1, &ast Qiang Wang, 2, &ast Xuzhen Liu, 1 Shuzhan Gao, 1 Sulin Ni, 1 Jing Sun, 1 Xijia Xu 1 1 Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing Brain Hospital, Nanjing, People's Republic of China; 2 Department of Medical Psychology, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xijia Xu, Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing Brain Hospital, Nanjing, People's Republic of China, Tel +86-13739192705, Email Purpose: Acute and transient psychotic disorder (ATPD), a psychosis frequently diagnosed, can potentially evolve into chronic conditions like schizophrenia (SCZ) and other mental disorders. This study aimed to develop a predictive model based on clinical data to forecast the transition from ATPD to SCZ and to identify the predictive factors. Methods: According to the diagnostic criteria issued by the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10), 396 inpatients diagnosed with ATPD were collected in this study. The Cox proportional-hazards regression model was performed using demographic data, clinical characteristics, and inflammatory markers to identify independent predictors for subsequent diagnostic transition (SDT) to SCZ. Results: During the follow-up period, 43.69% (n = 173) of ATPD patients had their diagnoses revised to SCZ. The multivariate Cox regression analysis identified post-treatment monocyte count, post-treatment monocyte/lymphocyte ratio (MLR), and the presence of schizophreniform symptoms as significant predictors for the diagnostic revision. Time-dependent receiver operating characteristic (TimeROC) analyses were developed. The AUC value at the 5-year follow-up was 0.728 for combined predictors, 0.702 for post-treatment monocyte count, 0.764 for post-treatment MLR, and 0.535 for the presence of schizophreniform symptoms. Conclusion: The combined predictors had good predictive ability for the diagnostic transition from acute and transient psychotic disorder to schizophrenia. Keywords: acute and transient psychotic disorder, Schizophrenia, inflammation, subsequent-diagnostic-transition, monocyte count, monocyte–lymphocyte ratio The annual incidence of ATPD varies significantly, with rates ranging from 3.9 per 100,000 people in the UK to 9.6 in Denmark. 1 The lifetime prevalence of Brief psychotic disorder (BPD) using the Diagnostic and Statistical Manual of Mental Disorders 5th ed. as the diagnostic criteria was lower than 0.1% in China, 2 and nearly two thirds of patients with ATPDs met the criteria for BPD. 3 ICD-10 endorses the concept of ATPD within the group of schizophrenia, schizotypal, and delusional disorders, characterized by an acute onset and a remission within 1 to 3 months. DSM-5 defines BPD based on the presence of at least four of the five core symptoms of schizophrenia, and the duration must be at least one day but less than one month. 4 A Meta-analysis revealed that 25% of ATPD cases converted into schizophrenia (SCZ) and related disorders within an average follow-up period of 6.3 years, and the risk factors associated with the elevated risk and accelerated progression to SCZ included younger age at onset, male gender, premorbid impairment, longer hospital admissions, first-rank symptoms, and family history. 5 Another meta-analysis found that 19% changed their diagnoses to SCZ spectrum psychoses on average follow-up of 47 months. 6 López-Díaz et al found that the role of premorbid adjustment and the presence of schizophreniform symptoms at the onset of psychosis were predictors of transition to schizophrenia in patients with first-episode ATPD. 7 While Wang et al demonstrated that only olanzapine-equivalent-Dosage of Antipsychotics at the End of the Hospitalization(DAEH) was significantly associated with the subsequent diagnostic transition (SDT) to SCZ. 8 Previous research highlighted the presence of persistent, low-grade inflammation in certain patients with SCZ. 9 Several studies reported leukocyte abnormalities in SCZ patients, particularly in inflammatory ratios such as the neutrophil/lymphocyte ratio (NLR), monocyte/lymphocyte ratio (MLR), and the ratio of neutrophil×platelet/lymphocyte, also known as the systemic immune inflammation index (SII). 10 Blood cell counts are routine items of examination for admitted patients and are reviewed afte -Abstract Truncated-
psychiatry,clinical neurology